key: cord-0796799-kznu1q3v authors: Xie, Hansheng; Zhao, Jianming; Lian, Ningfang; Lin, Su; Xie, Qunfang; Zhuo, Huichang title: Clinical characteristics of non‐ICU hospitalized patients with coronavirus disease 2019 and liver injury: A retrospective study date: 2020-04-12 journal: Liver Int DOI: 10.1111/liv.14449 sha: 5d7b73a76f0e6981b426b1c08008c43f1397d709 doc_id: 796799 cord_uid: kznu1q3v BACKGROUND & AIMS: Coronavirus disease 2019 (COVID‐19) has raised world concern for global epidemic since December, 2019. Limited data are available for liver function in COVID‐19 patients. We aimed to investigate the risk factors related to liver injury in the COVID‐19 patients. METHODS: A retrospective study was performed in non‐ICU Ward at Jinyintan Hospital from February 2, 2020 to February 23, 2020. Consecutively confirmed COVID‐19 discharged cases were enrolled. The clinical characteristics of patients with liver injury and without liver injury were compared. RESULTS: A total of 79 COVID‐19 patients were included. 31.6%, 35.4% and 5.1% COVID‐19 patients had elevated levels of alanine transaminase (ALT), aspartate aminotransferase (AST) and bilirubin respectively. Median value of ALT, AST and bilirubin for entire cohort was 36.5 (17.5 ~ 71.5) U/L, 34.5 (25.3 ~ 55.3) U/L and 12.7 (8.1 ~ 15.4) mmol/L respectively. There were no significant differences in age, previous medical history and symptoms between the two groups. Males were more likely to have liver injury when infected with COVID‐19 (P < .05); compared with patients without liver injury, patients with liver injury had increased levels of white blood cell counts, neutrophils, CRP and CT score (P < .05) and had a longer length of stay (P < .05). Logistic regression analyses suggested that the extent of pulmonary lesions on CT was a predictor of liver function damage (P < .05). CONCLUSIONS: Liver injury is common in non‐ICU hospitalized COVID‐19 patients. It may be related to systemic inflammation. Intense monitoring and evaluation of liver function in patients with severe pulmonary imaging lesions should be considered. Previous studies have found that ICU patients with COVID-19 had high risk for liver injury, but the cause of liver injury was not further analysed. 3, 4 In addition, previous studies had focused on liver injury in ICU patients, but less focused on non-ICU patients. This retrospective study included patients with confirmed COVID-19 in general ward, and intended to explore the possible influencing factors of liver injury and provided further information for mechanism. The retrospective study was conducted in non-ICU Ward at Wuhan Jinyintan Hospital. All consecutive discharged patients treated by Fujian Medical Team to aid Hubei province were enrolled in the study between February 2, 2020 and February 23, 2020. Jinyintan Hospital, located in Wuhan, Hubei Province is responsible for the treatments for COVID-19 assigned by the government. Including criteria: (a) All patients enrolled were diagnosed according to World Health Organization interim guidance with laboratory-identified COVID-19, 5 (b) with completed clinical data. Patients with viral hepatitis, alcoholic liver disease, liver malignancy or other known chronic liver disease were excluded from this study. This retrospective study was approved by the Ethics Committee of the Jinyintan Hospital, Wuhan province. The clinical data were collected from electronic medical records of Jinyintan Hospital. The clinical data were collected as follows: age, gender, chronic medical illness, symptoms, laboratory findings, chest computed tomographic (CT) scans and the duration of hospital stays. The data were collected and reviewed by a trained team of physicians. The patients were divided into moderate group and severe group according to the criteria of the diagnosis and treatment programme of novel coronavirus pneumonia (Trial sixth Edition). 6 If the clinical dates met any of the following: (a) Respiratory distress, breathing frequency ≥ 30 breaths/min; (b) In resting state, means oxygen saturation ≤93% and (c) Arterial blood oxygen partial pressure/oxygen concentration ≤300 mm Hg (1 mm Hg = 0.133 kPa), the patient were included in severe group. Others were included in moderate group. The clinical characteristics of patients with liver injury and those without liver injury were compared. All the patients with elevated levels of alanine transaminase (ALT), aspartate aminotransferase (AST) or bilirubin were defined as liver injury. All Patients completed lung CT scan within 2 days after admission. CT scans were reviewed and findings were scored prospectively by two respiratory and critical care physician in consensus. CT scores were assessed based on previous reports. 7 To quantify the extent of pneumonia, CT scores were assigned on the basis of the area involved (Table 1 ). There was a score of 0-5 for each lobe, with a total possible score of 0-25. Categorical variables were described as percentages, and continuous variables were described using mean ± SD or median (interquartile range) value. Means for continuous variables were compared using independent group t tests when the data were normally distributed; otherwise, the Mann-Whitney test was used. Categorical variables were compared using the χ 2 test; Fisher exact test was used when the data were limited. Furthermore, stepwise logistic regression models were built to identify independent risks of liver injury. All statistical analyses were performed using SPSS 22.0. The significance was recognized at a P < .05. A total of 79 cases with confirmed COVID-19 were included in this study. The median age was 60.0 years (range 27-87 years), and 44 • Liver injury is prevalent in COVID-19 patients. • Severe Lung lesions on CT might be related to higher incidence of liver injury. clinical characteristics of the two groups were compared. The ratio of male was higher in patients with liver damage than in patients without liver injury (P < .05). There were increased levels of white blood cell counts, neutrophils and CRP in the liver injury group (P < .05). The CT score of the liver injury group was significantly higher than that of the non-liver injury group (P < .05). The incidences of liver injury were 13.3%, 36.4% and 77.8% in the patients with CT scores of <5, 5-15 and >15 points respectively (χ 2 = 10.06, P = .007). All patients got improvement in clinical symptoms, negative coronavirus test and were discharged in this study, while patients with liver damage had longer length of stay than patients without liver injury (P < .05). The liver enzymes after treatment between patients with and without liver injury were not significantly different (Table 3) . Table 4 shows the correlations among baseline ALT, AST and the other variables. Both indices were significantly correlated with the ratio of male, CRP and D-dimer (all P < .05). CT scores, as an expression of the severity of COVID-19, was also correlated with ALT and AST (r = .524, P = .000 and r = .550, P = .000 respectively). And the level of white blood cell counts and neutrophils were correlated with ALT (both P < .05). Finally, stepwise logistic regression suggested that CT scores were an independent predictor for liver injury after adjusting for male, CRP and D-dimer (odds ratio [OR] = 5.265, 95% CI (1.025-1.371), P = .022). TA B L E 4 Spearman's rank correlation coefficients between liver enzyme levels (ALT and AST) and clinical characteristics The results of this retrospective study suggested that COVID-19 with liver injury in non-ICU hospitalized patients was common, and it may be related to the degree of CT lesions in the lung. Therefore, the close monitoring and evaluation of liver function in patients with severe pulmonary imaging lesions should be considered. This work was supported by the Natural Science Foundation of Fujian Province, China (no. 2019J01440), and Startup Fund for Scientific Research, Fujian Medical University, China (no. 2017XQ1080). The authors disclose no conflicts of interest. Lian Ningfang design study and revised the manuscript, Xie Hansheng analysis data and prepare the manuscript, Zhao Jianming collect data and perform manuscript drafting, Xie Qunfang and Zhuo Huichang search the literature and analysis data and Su Lin reviewed the results and made critical comments on the manuscript. Ningfang Lian https://orcid.org/0000-0003-2638-3372 Su Lin https://orcid.org/0000-0001-7517-9859 Clinical characteristics of hospitalized patients with SARS-CoV-2 infection: A single arm metaanalysis A novel coronavirus from patients with pneumonia in China A comparative study on the clinical features of COVID-19 pneumonia to other pneumonias Liver injury during highly pathogenic human coronavirus infections Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected: interim guidance Novel coronavirus pneumonia prevention and control program Pulmonary sequelae in convalescent patients after severe acute respiratory syndrome: evaluation with thin-section CT Preliminary study of the relationship between novel coronavirus pneumonia and liver function damage: a multicenter study Clinical features of patients infected with 2019 novel coronavirus in Wuhan Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan A pneumonia outbreak associated with a new coronavirus of probable bat origin Upregulation of hepatic angiotensin-converting enzyme 2 (ACE2) and angiotensin-(1-7) levels in experimental biliary fibrosis Exploring the mechanism of liver enzyme abnormalities in patients with novel coronavirus-infected pneumonia